Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company targeting emerging markets, announced that its Chief Executive Officer, Dr. Kevin Rodan Levy, will attend HLTH Europe 2026. The conference, scheduled for June 15-18 in Amsterdam, convenes healthcare executives, innovators, investors, and technology leaders to discuss healthcare transformation and digital infrastructure.
The company views participation in major international healthcare conferences as a strategic opportunity to monitor industry developments, strengthen professional networks, and advance its telehealth and AI healthcare platform strategy. Dr. Levy stated, “As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning.”
Catalyst Crew Technologies is developing telehealth infrastructure and healthcare analytics platforms for Latin America and other emerging markets. Its participation in HLTH Europe aligns with broader efforts to evaluate emerging technologies and explore strategic relationships that could support the continued development and expansion of its digital health ecosystem. The company is actively transitioning into an AI-enabled healthcare provider, focusing on telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
The announcement comes as the company continues to advance its platform development. For more information, visit the company’s website at https://catalystcrewai.com or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Catalyst Crew Technologies is a development-stage enterprise and has not yet generated revenues from its newly announced business direction. The company faces risks associated with implementing its business plan, securing financing, completing acquisitions, and obtaining regulatory approvals. Prospective investors are urged to carefully review all risk factors and disclosures contained in the company’s SEC filings before making any investment decision.
